Company Pharma Sa with Fiscal Code 13591928
recorded a turnover of 2024 of
46.234.614,
with a net profit of
563.512
and having an average number of employees of
170.
The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Pharma Sa
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
26.266.231
28.055.096
26.016.067
23.320.397
26.527.793
28.970.056
33.239.886
37.201.031
38.275.923
46.234.614
Total Income - EUR
26.359.618
28.140.602
26.139.213
23.345.730
26.630.253
28.999.203
33.294.266
37.247.734
38.417.516
46.635.750
Total Expenses - EUR
25.862.896
27.514.406
25.620.180
22.897.887
26.168.511
28.647.368
32.543.058
36.797.350
37.882.439
45.990.848
Gross Profit/Loss - EUR
496.722
626.196
519.032
447.844
461.742
351.834
751.208
450.384
535.077
644.902
Net Profit/Loss - EUR
443.317
551.287
423.224
405.204
389.695
275.540
611.402
417.163
477.088
563.512
Employees
153
139
137
135
143
147
161
169
161
170
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 21.5%, from 38.275.923 euro in the year 2023, to 46.234.614 euro in 2024.
The Net Profit increased by 89.090 euro, from 477.088 euro in 2023, to 563.512 in the last year.
Check the financial reports for the company - Pharma Sa
Financial Rating - PHARMA SA
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Pharma Sa
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Pharma Sa
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Pharma Sa
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Pharma Sa - CUI 13591928
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
3.216.759
3.166.834
2.915.272
3.039.818
3.304.655
3.548.566
5.034.397
5.203.425
5.101.827
5.457.925
Current Assets
23.455.473
24.106.498
24.800.238
23.854.608
26.617.632
25.685.205
24.285.049
21.337.533
23.238.255
29.833.179
Inventories
12.656.896
13.675.415
14.372.719
14.558.645
15.374.219
12.831.131
10.489.998
8.172.319
9.450.970
13.375.426
Receivables
9.974.241
10.069.554
10.111.034
9.004.505
10.199.984
11.966.572
12.595.940
12.636.341
13.147.399
15.982.270
Cash
824.336
361.529
316.484
291.458
1.043.430
887.501
1.199.111
528.873
639.886
475.483
Shareholders Funds
3.562.702
4.077.654
4.380.935
4.712.906
5.011.648
5.052.633
7.046.248
7.470.372
7.924.807
8.403.067
Social Capital
44.994
44.535
43.782
42.978
42.146
41.347
40.430
40.556
40.433
40.207
Debts
23.131.811
23.218.764
23.248.338
22.194.073
24.929.159
24.211.542
22.309.719
19.108.596
20.486.420
27.180.647
Income in Advance
0
0
0
0
0
0
0
0
0
19.022
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4646 - 4646"
CAEN Financial Year
4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
29.833.179 euro in 2024 which includes Inventories of
13.375.426 euro, Receivables of
15.982.270 euro and cash availability of
475.483 euro.
The company's Equity was valued at
8.403.067 euro, while total Liabilities amounted to
27.180.647 euro.
Equity increased by 522.549 euro, from 7.924.807 euro in 2023, to 8.403.067 in 2024.
The Debt Ratio was 76.3% in the year 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Pharma Sa